glp 1 research GLP-1 weight loss drugs leave users low on key nutrients, study finds Discovery of GLP-1–Based Drugs for
Description
I have six children of my own and had my last at the age of 40
At least two clinical trials are currently ongoing for OUD, investigating both liraglutide (Freet et al., 2024) and semaglutide (Freet et al., 2025)
doi: 10.3390/ijms221910822
However, medical outcomes are heavily dependent on how consistently a patient can follow the required administration rules
Ozempic, Wegovy and Mounjaro are all administered on a weekly basis through a subcutaneous injection, with the outlier being Mounjaro due to the significantly higher starting dosage (2.5mg compared to 0.5mg for the other two)
